P11309 (PIM1_HUMAN) Homo sapiens (Human)

Serine/threonine-protein kinase pim-1 UniProtKBInterProSTRINGInteractive Modelling

313 aa; Sequence (Fasta) ; (Isoform 2); 10 identical sequences: Pongo abelii: K7EV18; Pan troglodytes: A0A2J8NZC1; Gorilla gorilla gorilla: G3S2M1; Theropithecus gelada: A0A8D2KAV1; Macaca mulatta: H9YX84; Macaca fascicularis: A0A2K5W2N0; Cercocebus atys: A0A2K5P1I7; Rhinopithecus roxellana: A0A2K6QPX1; Chlorocebus sabaeus: A0A0D9RDG7; Piliocolobus tephrosceles: A0A8C9IHA9

Available Structures

182 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of PIM1 in complex with ARC-3126monomer1-305
PO4;EDO;
Assess
Crystal structure of human Pim-1 in complex with DAPPAmonomer32-308
985;MG;
Assess
Structure of PIM-1 kinase bound to 5-(4-cyanobenzyl)-N-(4-fluorophenyl)-7-hydroxypyrazolo[1,5-a]pyr…monomer32-308
PO4;1OB;
Assess
Crystal Structure of hPim-1 kinase at 2.1 A resolutionmonomer32-308
Assess
Crystal structure of hPim-1 kinase in complex with AMP-PNP at 2.1 A Resolutionmonomer32-308
MG;ANP;
Assess
CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU1monomer32-306
HB1;EDO;CL;
Assess
Pim1 Complexed with a pyridylcarboxamidemonomer32-306
2HX;
Assess
Crystal structure of human PIM1 in complex with fluorinated ruthenium pyridocarbazolemonomer32-306
CL;JM1;EDO;EPE;
Assess
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioa…monomer33-307
LYG;
Assess
Protein kinase Pim-1 in complex with fragment-4 from crystallographic fragment screenmonomer33-307
XJ0;
Assess
Human PIM1 bound to benzothiophene inhibitor 224monomer32-305
OCJ;GOL;EDO;
Assess
PIM1 kinase in complex with Compound 1smonomer32-305
3YR;
Assess
Structure of PIM-1 kinase bound to N-(4-fluorophenyl)-7-hydroxy-5-(piperidin-4-yl)pyrazolo[1,5-a]py…monomer33-306
1OA;PO4;
Assess
Crystal Structure of Kinase Pim1 in complex with (3E)-3-[(4-HYDROXYPHENYL)IMINO]-1H-INDOL-2(3H)-ONEmonomer33-306
IMD;LI7;
Assess
Crystal Structure of Kinase Pim1 in complex with 3,4-Dihydroxy-1-methylquinolin-2(1H)-onemonomer33-306
IMD;LI6;
Assess
Crystal Structures of Proto-Oncogene Kinase Pim1: a Target of Aberrant Somatic Hypermutations in Di…monomer33-306
IMD;
Assess
Identification of N-(4-((1R,3S,5S)-3-amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-…monomer33-306
5H7;
Assess
Crystal Structure of Kinase Pim1 in complex with AMPPNPmonomer33-306
ANP;
Assess
Crystal structure of Pim1 with Myricetinmonomer33-306
IMD;MYC;
Assess
Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensu…monomer33-306
CL;7CP;
Assess
Design, synthesis and structure activity relationship of potent pan-PIM kinase inhibitors derived f…monomer32-305
PEG;6CB;
Assess
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioa…monomer33-306
LWG;
Assess
The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitorsmonomer33-306
IMD;UNJ;
Assess
Protein kinase Pim-1 in complex with small molecule inibitormonomer33-306
XJ1;
Assess
Pim-1 kinase in complex with a 7-azaindolemonomer33-306
IMD;7AU;
Assess
Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensu…monomer32-305
NM8;NA;CL;
Assess
Crystal Structure of Kinase Pim1 with P123M mutationmonomer33-306
IMD;
Assess
Protein kinase Pim-1 in complex with small molecule inhibitormonomer33-306
985;
Assess
Human PIM1 bound to benzothiophene inhibitor 213monomer32-305
O97;GOL;
Assess
Protein kinase Pim-1 in complex with fragment-2 from crystallographic fragment screenmonomer33-306
XIY;DMS;CL;GOL;
Assess
Protein kinase Pim-1 in complex with fragment-3 from crystallographic fragment screenmonomer33-306
XIZ;
Assess
Pim-1 kinase in complex with a 7-azaindolemonomer33-306
IMD;7AJ;
Assess
Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase…monomer33-306
IMD;0FS;
Assess
Crystal structure of Pim1 with Quercetinmonomer33-306
IMD;QUE;
Assess
Discovery of Pyrazolo[1,5a]pyrimidine-based Pim1 Inhibitorsmonomer33-306
26K;
Assess
Crystal structure of PIM1 kinase with ETP46546monomer32-305
E46;IMD;ACT;
Assess
Human PIM1 bound to benzothiophene inhibitor 292monomer32-305
OD4;GOL;
Assess
Crystal structure of Pim1 kinase in complex with inhibitor 2-[(trans-4-aminocyclohexyl)amino]-4-{[3…monomer33-306
1N6;
Assess
Protein kinase Pim-1 in complex with fragment-1 from crystallographic fragment screenmonomer33-306
XIX;
Assess
Crystal structure of Pim1 with Quercetagetinmonomer33-306
IMD;MYU;
Assess
Crystal structure of Pim1 kinasemonomer33-306
Assess
The human protein kinase Pim1 in complex with its consensus peptide Pimtidemonomer33-306
BI1;
Assess
Benzofuropyrimidinone Inhibitors of Pim-1monomer33-306
IMD;R9P;
Assess
Pim1 complexed with a novel 3,6-disubstituted indole at 2.6 Ang Resolutionmonomer33-306
3T9;
Assess
Discovery of Pyrazolo[1,5a]pyrimidine-based Pim1 Inhibitorsmonomer33-306
26L;
Assess
Pim1 Complexed with a phenylcarboxamidemonomer32-305
2HV;
Assess
Benzofuropyrimidinone Inhibitors of Pim-1monomer33-306
IMD;79O;
Assess
The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitorsmonomer33-306
IMD;UNE;
Assess
Crystal Structures of PIM1 in Complex with Macrocyclic Compound H3monomer32-305
I4M;
Assess
Crystal structure of human Pim1 kinase complexed with 4-(4-hydroxy-3-methyl-phenyl)-6-phenylpyrimid…monomer32-305
55E;
Assess
Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as Potent, Highly Selective and Orally Bioa…monomer33-306
LXG;
Assess
Crystal structure of Pim1 with Pentahydroxyflavonemonomer33-306
IMD;MYF;
Assess
Structure of PIM-1 kinase crystallized in the presence of P27KIP1 Carboxy-terminal peptidemonomer33-305
MG;ANP;
Assess
PIM1 in complex with Cpd16 (5-amino-N-(5-((4R,5R)-4-amino-5-fluoroazepan-1-yl)-1-methyl-1H-pyrazol-…monomer33-305
GOL;PO4;KUV;
Assess
Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivativesmonomer33-305
E2X;
Assess
Human Pim1 phosphorylated on Ser261monomer33-305
BI1;CL;
Assess
Crystal Structure of the human PIM1 kinase domainmonomer33-305
SO4;BI1;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and fragment like moleku…monomer33-305
8MW;GOL;
Assess
Novel and selective pan-PIM kinase inhibitormonomer33-305
EDO;7LI;SO4;
Assess
Human Pim-1 kinase in complex with an inhibitor identified by virtual screeningmonomer33-305
OWB;GOL;ACT;
Assess
Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivativesmonomer33-305
E2R;
Assess
PIM1 kinase in complex with Cpd17 (1-(6-(4,4-difluoropiperidin-3-yl)pyridin-2-yl)-6-(6-methylpyrazi…monomer34-306
96Y;
Assess
Pim1 in complex with (E)-4-(4-hydroxystyryl)benzoic acid and Pimtidemonomer33-305
GOL;XGK;EDO;
Assess
Crystal structure of PIM1 in complex with a Pyrrolo(1,2-a)Pyrazinone inhibitormonomer33-305
UGX;
Assess
Crystal Structure of the humab PIM1 in complex with LY333531monomer33-305
SO4;LY4;
Assess
CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU2monomer33-305
DW2;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensus peptide and fragment like molec…monomer33-305
8MN;
Assess
Benzofuropyrimidinone Inhibitors of Pim-1monomer34-306
IMD;HY7;
Assess
Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivativesmonomer33-305
E2L;
Assess
Crystal structure of PIM1 in complex with ARC-1415monomer33-305
MG;EDO;
Assess
Crystal structure of PIM1 with inhibitor: 2-(5-chloranyl-1~{H}-indol-3-yl)ethanaminemonomer33-305
CL; 21×EDO;6SO;SO4;
Assess
Pim1 in complex with (E)-4-((2-oxoindolin-3-ylidene)methyl)benzoic acid and Pimtidemonomer33-305
GOL;AY3;
Assess
Pim-1 kinase in complex with Ruthenium-based inhibitormonomer33-305
RUI;SO4;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and fragment like moleku…monomer33-305
8ET;GOL;
Assess
Crystal structure of PIM1 in complex with ARC-1411monomer33-305
SO4;EDO;
Assess
PIM1 in complex with Cpd36 ((1S,3S)-N1-(6-(5-(pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridin-3-yl)pyridin-…monomer33-305
5E6;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and [2-oxo-2-(1H-pyrrol-…monomer33-305
8NZ;GOL;
Assess
Crystal structure of PIM1 with inhibitor: 2-pyridin-3-yl-1~{H}-benzimidazolemonomer33-305
19×EDO;6SL;SO4;
Assess
Pim-1 Kinase Domain in Complex with 3-aminophenyl-7-azaindolemonomer33-305
IMD;C4E;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensus peptide and fragment like molec…monomer33-305
GOL;8UB;
Assess
Human Pim-1 kinase in complex with an triazolo pyridazine inhibitor VX2monomer33-305
VX2;
Assess
Human proto-oncogene serine threonine kinase (PIM1) in complex with a consensus peptide and Leucett…monomer33-305
3RA;EDO;
Assess
Pim1 in complex with 4-(4-aminophenethyl)benzoic acid and Pimtidemonomer33-305
GOL;XIJ;
Assess
Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensu…monomer33-305
CL;MB9;EDO;
Assess
Crystal structure of proto-oncogene kinase Pim1 bound to hispidulinmonomer33-305
HUL;
Assess
CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH A RUTHENIUM ORGANOMETALLIC LIGAND RU3monomer33-305
ME3;
Assess
Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivativesmonomer33-305
E2C;
Assess
PIM-inhibitor complex 1monomer34-306
IMD;ROY;ACT;
Assess
Structure of PIM-1 kinase bound to N-(5-(2-fluorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)-5-((((3R,4R…monomer33-305
PO4;1OC;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensus peptide and fragment like molec…monomer33-305
8M8;
Assess
Crystal structure of Ser/Thr kinase Pim1 in complex with Mitoxantrone derivativesmonomer33-305
3O8;
Assess
Crystal structure of PIM1 in complex with a Pyrrolo-Pyrazinone inhibitormonomer33-305
676;
Assess
Crystal structure of human Pim-1 kinase in complex with a quinazolinone-pyrrolopyrrolone inhibitor.monomer33-305
6CD;GOL;
Assess
Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivativesmonomer33-305
E2U;
Assess
Crystal structure of human Pim-1 kinase in complex with an imidazopyridazine inhibitor.monomer33-305
6YN;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensus peptide and fragment like molec…monomer33-305
8N8;
Assess
Crystal structure of PIM1 with inhibitor 2-[3,4-bis(chloranyl)phenoxy]ethanaminemonomer33-305
13×EDO;6SF;SO4;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensus peptide and fragment like molec…monomer33-305
GOL;8MQ;
Assess
Pim1 with N82K mutationmonomer33-305
Assess
Crystal structure of Pim-1 bound to staurosporinemonomer33-305
STU;
Assess
Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensu…monomer33-305
EDO;JN5;
Assess
Pim1 in complex with 4-((6-hydroxybenzofuran-3-yl)methyl)benzoic acid and Pimtidemonomer33-305
M0F;
Assess
Crystal structure of human Pim-1 kinase in complex with a quinazolinone-pyrrolodihydropyrrolone inh…monomer33-305
JYG;GOL;
Assess
Crystal structure of Pim-1 kinase domain in complex with 2-methyl-5-phenylfuran-3-carboxylic acidmonomer33-305
2D2;GOL;
Assess
Crystal structure of human Pim-1 kinase in complex with an azaspiro pyrazinyl-indazole inhibitor.monomer33-305
GOL;3U1;
Assess
Crystal structure of human Pim-1 kinase in complex with a macrocyclic quinoxaline-pyrrolodihydropip…monomer33-305
5QO;GOL;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and fragment like moleku…monomer33-305
8MT;
Assess
Pim1 Complexed with a pyridylcarboxamidemonomer33-305
2HW;GOL;
Assess
Pim1 in complex with 4-(4-hydroxystyryl)benzoic acid and Pimtidemonomer33-305
XGQ;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and (R)-3-(2-((isoquinol…monomer33-305
8O8;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and fragment like moleku…monomer33-305
8MB;
Assess
Crystal structure of PIM1 with inhibitor: 5-(3,4-dichlorophenyl)-1~{H}-pyrazol-3-aminemonomer33-305
15×EDO;6SN;SO4;
Assess
Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivativesmonomer33-305
E2F;
Assess
Crystal Structure of Kinase Pim1 in Complex with AMPmonomer33-305
IMD;AMP;
Assess
PIM1 kinase in complex with Cpd1 (1-methyl-4-(3-(6-(piperazin-1-yl)pyridin-2-yl)-1H-pyrazolo[3,4-c]…monomer33-305
PO4;971;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensus peptide and fragment like molec…monomer33-305
8N2;
Assess
Pim1 in complex with (E)-4-((6-amino-2-oxoindolin-3-ylidene)methyl)benzoic acid and Pimtidemonomer33-305
GOL;IJB;
Assess
Cyclometalated Phthalimides as Protein Kinase Inhibitorsmonomer33-305
RPS;
Assess
Crystal structure of human Pim-1 kinase in complex with a thiadiazolamine-indole inhibitor.monomer33-305
3U6;GOL;
Assess
Crystal structure of human Pim-1 kinase in complex with a thiazolamine-indazole inhibitor.monomer33-305
3U5;GOL;
Assess
Pim-1 kinase in complex with a 7-azaindolemonomer34-306
7GK;
Assess
Crystal structure of Ser/Thr kinase Pim1 in complex with Mitoxantrone derivativesmonomer33-305
3OA;
Assess
Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensu…monomer33-305
1DR;
Assess
Crystal structure of the human Pim1 in complex with an osmium compoundmonomer33-305
SO4;DWC;
Assess
PIM1 in complex with Cpd9 ((R)-5-amino-N-(3-(4-aminoazepan-1-yl)-1H-pyrazol-4-yl)-2-(2,6-difluoroph…monomer33-305
KUY;PO4;
Assess
Structure of Pim-1 bound to adenosinemonomer33-305
ADN;
Assess
Human Pim-1 kinase in complex with diphenyl indole inhibitor VX3monomer33-305
VX3;
Assess
CRYSTAL STRUCTURE OF THE HUMAN PIM1 IN COMPLEX WITH AMPPNP AND PIMTIDEmonomer33-305
ANP;
Assess
Pim1 in complex with 6-bromobenzo[d]oxazol-2-amine and Pimtidemonomer33-305
XIP;
Assess
PIM1 in complex with Cpd4 (3-methyl-5-(pyridin-3-yl)-1H-pyrazolo[3,4-c]pyridine)monomer33-305
5E5;PO4;
Assess
Crystal structure of human PIM-1 Kinase in complex with inhibitormonomer33-305
VRV;
Assess
Crystal Structure of Pim-1 bound to LY294002monomer33-305
LY2;
Assess
Crystal structure of PIM1 in complex with a Pyrrolo-Pyrazinone compoundmonomer33-305
JYO;
Assess
Discovery of 3,5-substituted 6-azaindazoles as potent pan-Pim inhibitorsmonomer33-305
L20;PO4;
Assess
Pim1 in complex with (E)-4-((6-amino-1-methyl-2-oxoindolin-3-ylidene)methyl)benzoic acid and Pimtidemonomer33-305
GOL;A7X;
Assess
Crystal structure of Ser/Thr kinase Pim1 in complex with Mitoxantrone derivativesmonomer33-305
3O7;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensus peptide and fragment like molec…monomer33-305
8N5;
Assess
Human PIM1 kinase in complex with compound 12bmonomer33-305
EDO;MVG;SO4;
Assess
Crystal structure of Ser/Thr kinase Pim1 in complex with 10-DEBC derivativesmonomer33-305
E2O;
Assess
Crystal structure of Ser/Thr kinase Pim1 in complex with Mitoxantrone derivativesmonomer33-305
3OK;
Assess
Crystal structure of PIM1 with inhibitor: 3-(4-methoxyphenyl)-1~{H}-pyrazol-5-aminemonomer33-305
EDO;6SD;SO4;
Assess
Crystal Structure of human Ser/Thr kinase Pim1 in complex with mitoxantronemonomer33-305
MIX;
Assess
Crystal structure of human Pim-1 kinase in complex with an aminooxadiazole-indole inhibitor.monomer33-305
38W;GOL;
Assess
Human Pim-1 complexed with a benzoisoxazole inhibitor VX1monomer33-305
VX1;
Assess
Crystal structure of Ser/Thr kinase Pim1 in complex with thioridazine derivativesmonomer33-305
RTX;
Assess
Crystal structure of Ser/Thr kinase Pim1 in complex with thioridazinemonomer33-305
RTZ;
Assess
Pim-1 kinase in complex with a 7-azaindolemonomer34-306
7LK;
Assess
Serine/threonine-protein kinase pim-1monomer33-305
4YK;
Assess
co-crystal structure of Pim1 with compound 3monomer33-305
3UR;
Assess
Crystal Structure of Pim-1 in complex with the fluorescent compound SKF86002monomer34-305
SK8;GOL;CA;
Assess
Pim-1 kinase in Complex with a Selective N-substituted 7-azaindole Inhibitormonomer34-305
IMD;ACT;6S3;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensuspeptide and fragment like moleku…monomer34-305
8MZ;
Assess
Pim1 in complex with 4-(4-hydroxyphenethyl)benzoic acid and Pimtidemonomer34-305
XIT;
Assess
Crystal structure of human Pim-1 kinase in complex with a consensus peptide and fragment like molec…monomer34-305
8MK;
Assess
Crystal structure of PIM1 kinase in complex with small-molecule inhibitormonomer34-305
1RO;IMD;
Assess
Crystal structure of PIM1 kinase in complex with small-molecule inhibitormonomer34-305
3NG;IMD;GOL;CL;
Assess
Crystal structure of PIM1 kinase in complex with small-molecule inhibitormonomer34-305
9G5;IMD;CL;
Assess
Pim1 complexed with N-(6-(4-hydroxyphenyl)-1H-indazol-3-yl)cyclopropanecarboxamidemonomer34-305
C2J;
Assess
The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitorsmonomer35-305
UNQ;IMD;
Assess
Discovery of SARxxxx92, a pan-PIM kinase inhibitor, efficacious in a KG1 tumor modelmonomer35-305
WFY;GOL;
Assess
Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase…monomer35-305
0F5;
Assess
The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitorsmonomer35-305
UNM;IMD;
Assess
Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase…monomer35-305
0FO;
Assess
Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase…monomer35-305
0FK;
Assess
Human PIM1 bound to OX0999monomer35-305
JKW;
Assess
Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase…monomer35-305
0F9;
Assess
Crystal structure of Pim1 in complex with 2-{4-[(3-aminopropyl)amino]quinazolin-2-yl}phenol (result…monomer35-305
Q17;GOL;
Assess
Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase…monomer35-305
0FR;IMD;
Assess
Human PIM1 bound to benzothiophene inhibitor 354monomer35-305
OD1;
Assess
Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in Pim-1 kinase…monomer35-305
0FN;
Assess
Pim1 Kinase in complex with a benzofuranone inhibitormonomer36-305
GOL;8GU;
Assess
Pim1 Kinase in complex with a benzofuranone inhibitormonomer36-305
GOL;8GR;
Assess
Pim1 Kinase in complex with a benzofuranone inhibitormonomer36-305
GOL;PO4;8GX;
Assess
Human PIM1 bound to benzothiophene inhibitor 379monomer36-305
SO4;OBY;
Assess
CRYSTAL STRUCTURE OF HUMAN PIM1 IN COMPLEX WITH IMIDAZOPYRIDAZIN Imonomer37-305
IYZ;
Assess
Crystal structure of Pim1 kinase in complex with small molecule inhibitormonomer37-305
Q17;CL;SO4;CA;GOL;
Assess
Crystal structure of human proto-oncogene serine threonine kinase (PIM1) in complex with a consensu…monomer37-305
01I;
Assess
Crystal structure of Pim1 in complex with the inhibitor Quercetin (resulting from displacement of S…monomer36-304
QUE;GOL;
Assess
Crystal Structure of Pim-1 Kinase in complex with inhibitor (2E,5Z)-2-(2-chlorophenylimino)-5-(4-hy…monomer37-305
PO4;Z20;
Assess
Crystal Structure of Pim-1 kinase in complex with (2E,5Z)-2-(2-chlorophenylimino)-5-(4-hydroxy-3-me…monomer37-305
DMS;GOL;PO4;J19;
Assess
Crystal structure of Pim1 kinase in complex with inhibitor (Z)-2-[(1H-indazol-3-yl)methylene]-6-met…monomer37-304
GOL;SO4;596;
Assess
Crystal structure of Pim1 kinase in complex with inhibitor (Z)-2-[(1H-indol-3-yl)methylene]-7-(azep…monomer37-304
Q18;SO4;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1xws.1.Amonomer0.9133-305
BI1;100.00
Assess

1 SWISS-MODEL model built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24rpv.1.Amonomer0.89124-396
3UR;100.00
Assess